PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4-methylanisole | 203-253-7 | 104-93-8 | 2 | - | - | - | 1 | - | - | - | - | Details |
| 4-methylbenzophenone | 205-159-1 | 134-84-9 | - | - | 2 | - | - | - | - | - | - | Details |
| 4-methylcyclohexanone | 209-665-3 | 589-92-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 4-methylimidazole | 212-497-3 | 822-36-6 | - | - | - | - | 1 | 1 | - | - | - | Details |
| 4-methylmorpholine | 203-640-0 | 109-02-4 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 4-methylmorpholine 4-oxide, monohydrate | 231-391-8 | 7529-22-8 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 4-methylpent-3-en-2-one | 205-502-5 | 141-79-7 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-methylpentan-2-one | 203-550-1 | 108-10-1 | - | - | 2 | - | - | 1 | - | - | - | Details |
| 4-methylpiperidine | 210-954-1 | 626-58-4 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-methylpyrazole | 231-445-0 | 7554-65-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-methylpyridine | 203-626-4 | 108-89-4 | - | - | 1 | - | - | - | - | - | - | Details |
| 4-methylstyrene | 210-762-8 | 622-97-9 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 4-methylthiosemicarbazide | 229-563-2 | 6610-29-3 | - | - | 1 | - | - | - | - | - | - | Details |
| 4-methylvaleric acid | 211-464-0 | 646-07-1 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-morpholinecarbaldehyde | 224-518-3 | 4394-85-8 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 4-Morpholineethanamine, hydrochloride (1:2) | 611-095-9 | 5409-41-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-MORPHOLINO-2-NAPHTHOL | 435-700-9 | - | - | - | - | - | 1 | - | - | - | - | Details |
| 4-Morpholinopiperidine | 627-580-3 | 53617-35-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-morpholinopropanesulphonic acid | 214-478-5 | 1132-61-2 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 4-N-(4-methylpentan-2-yl)-1-N-phenylcyclohexa-2,5-diene-1,4-diimine | 429-640-2 | 52870-46-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-nitro-m-xylene | 201-947-4 | 89-87-2 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-nitro-o-xylene | 202-761-6 | 99-51-4 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-nitrobenzaldehyde | 209-084-5 | 555-16-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-nitrobenzoic acid | 200-526-2 | 62-23-7 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-nitrobenzoyl chloride | 204-517-4 | 122-04-3 | - | - | - | - | 1 | - | - | - | - | Details |